[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Clinicopathologic Reports, Case Reports, and Small Case Series
May 01, 2005

Transient Cortical Blindness With Leptomeningeal Enhancement After Attempted Peripherally Inserted Central Venous Catheter Placement

Arch Ophthalmol. 2005;123(5):700-702. doi:10.1001/archopht.123.5.700

Transient cortical blindness is an infrequent complication of endovascular procedures.13 We describe a patient who developed transient cortical blindness associated with focal leptomeningeal enhancement on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) following attempted placement of a peripherally inserted central venous catheter (PICC).

Report of a Case

A 57-year-old woman with metastatic carcinoma of the colon, which had spread to the liver and peritoneum, was hospitalized for partial small-bowel obstruction. Placement of a PICC for total parenteral nutrition (TPN) was attempted with inadvertent cannulation of the brachial artery and infusion of 10 mL of nonheparinized normal saline. The catheter was promptly removed; however, the patient began to complain of blurred vision in each eye approximately 15 minutes after the attempted PICC placement. During the procedure, the patient was hypertensive and tachycardic with a blood pressure of 170/120 mm Hg and a heart rate of 120 beats per minute. The patient's blood pressure was controlled with low-dose oral metoprolol.

After the procedure, the patient complained of progressive visual loss, headache, and malaise, which progressed to complete binocular visual loss during the ensuing 4 hours. Ophthalmic examination revealed no light perception vision bilaterally and briskly reactive pupils, without a relative afferent pupillary defect. The anterior segment, extraocular motility, and dilated funduscopy findings were normal in each eye. Findings from the remainder of the neurologic examination were otherwise normal.

Contrast-enhanced MRI obtained 4 hours after the onset of visual loss revealed focal leptomeningeal enhancement in the occipital lobes and superior cerebellum (Figure 1). Diffusion-weighted images showed no evidence of ischemia, and magnetic resonance angiography demonstrated normal cerebral vasculature.

Figure 1.
Sagittal (left) and axial (right) contrast-enhanced T1-weighted magnetic resonance images reveal focal leptomeningeal enhancement (arrows) in the occipital lobes and superior cerebellum, and an old right basal ganglia infarct.

Sagittal (left) and axial (right) contrast-enhanced T1-weighted magnetic resonance images reveal focal leptomeningeal enhancement (arrows) in the occipital lobes and superior cerebellum, and an old right basal ganglia infarct.

Lumbar puncture showed an elevated protein level of 119 mg/dL and a normal glucose level of 81 mg/dL with a normal opening pressure. No atypical cells or white blood cells were seen. The results for cerebrospinal fluid cultures and blood cultures were negative. Twenty-four hours after the onset of visual loss, the patient experienced 2 generalized seizures, which were controlled with intravenous dexamethasone and phenytoin.

During the following week, the patient's symptoms gradually improved. After 72 hours from the time of onset of visual loss, she had light perception in both eyes, and after 5 days, visual acuity was 20/400 OD and 20/800 OS. Nine days after the initial insult, the patient's visual acuity was 20/20 OD and 20/30 OS with normal visual fields by confrontation, and repeat MRI revealed resolution of the focal leptomeningeal enhancement (Figure 2). A repeat lumbar puncture revealed a protein level of 54 mg/dL, a glucose level of 126 mg/dL, and a normal opening pressure. No abnormal cells were seen on cytologic examination.

Figure 2.
Interval sagittal and axial contrast-enhanced T1-weighted magnetic resonance images after visual improvement reveal resolution of the contrast enhancement in the occipital lobes.

Interval sagittal and axial contrast-enhanced T1-weighted magnetic resonance images after visual improvement reveal resolution of the contrast enhancement in the occipital lobes.

Comment

Transient cortical blindness following vascular intervention has been described primarily after contrast-enhanced coronary, cerebral, and other arterial perfusion studies.13 Inadvertent arterial entry during venous catheterization has resulted in cortical blindness in 2 prior reports.4,5 In both of those patients, arterial infusion of TPN resulted in transient bilateral visual loss with occipital lobe abnormalities on neuroimaging. In the first report, MRI showed leptomeningeal enhancement around the occipital cortices, similar to that seen in our patient, following TPN infusion into the right vertebral artery. The visual symptoms improved in 2 weeks with a residual right homonymous hemianopia.4 In the second report, a left homonymous hemianopia and visual hallucinations occurred following TPN infusion into the right subclavian artery. This patient experienced sudden bilateral visual loss after the onset of TPN infusion, which improved after several minutes, and flashes of light each time her central line was flushed with normal saline. Ophthalmic examination showed a left homonymous hemianopia that resolved after 3 days. Magnetic resonance imaging showed multifocal infarcts in the occipital and parietal cortices and in the right cerebellum.5

The mechanisms causing visual loss following contrast and TPN infusion remain unclear. However, several authors have postulated that the hyperosmolarity of these agents may lead to osmotic disruption of the blood-brain barrier and subsequent cortical blindness through direct neurotoxic effects.6,7 Experimental studies have demonstrated that hyperosmolar agents induce vasodilation, shrinkage of cerebrovascular endothelial cells, and widened endothelial tight junctions.8

The focal leptomeningeal enhancement noted on the contrast-enhanced MRI in our patient suggests that disruption of the blood-brain barrier occurred in the vertebrobasilar distribution. It is unclear whether the nonheparinized normal saline rinse disrupted the blood-brain barrier in our patient, but the timing of the visual symptoms with the catheterization of the brachial artery suggests an iatrogenic vascular cause for the patient's symptoms. A possible contributing factor was the patient's elevated blood pressure because hypertensive encephalopathy may cause transient cortical blindness associated with reversible cerebral edema on neuroimaging.9

Leptomeningeal enhancement may occur from infection, cerebrovascular disorders, neoplasia, inflammatory conditions, and iatrogenic causes10,11(Table). In our patient, the pattern of radiographic enhancement could have been attributed to carcinomatous meningitis. However, repeat cerebrospinal fluid examinations revealed no atypical cells. Although cerebrospinal fluid cytology is falsely negative in 10% of patients,12 the rapid resolution of the radiographic and clinical abnormalities makes the diagnosis of carcinomatous meningitis unlikely. Infectious meningitis was also considered in the differential diagnosis, but the patient demonstrated no signs of infection and laboratory studies did not reveal a source of infection. Scattered cerebral infarction from arterial air emboli was unlikely because no evidence of ischemia was detected on a diffusion-weighted MRI.

Table. 
Differential Diagnosis of Leptomeningeal Enhancement
Differential Diagnosis of Leptomeningeal Enhancement

The timing of cortical blindness in our patient, shortly after inadvertent arterial entry during attempted PICC line placement, and the focal leptomeningeal enhancement on MRI suggest that breakdown of the blood-brain barrier was iatrogenic. The precise mechanisms underlying this process remain unclear, but we postulate that transient hyperosmolarity and hypertension may have been involved in the pathogenesis of our patient's symptoms.

Back to top
Article Information

Correspondence: Dr Foroozan, Neuro-Ophthalmology Service, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin NC-205, Houston, TX 77030 (foroozan@bcm.tmc.edu).

Financial Disclosure: None.

References
1.
Hinchey  JSweeney  PJ Transient cortical blindness after coronary angiography. Lancet 1998;3511513- 1514
PubMedArticle
2.
Shyn  PBBell  KA Transient cortical blindness following cerebral angiography. J La State Med Soc 1989;14135- 37
PubMed
3.
Alsarraf  RCarey  JSires  BSPinczower  E Angiography contrast-induced transient cortical blindness. Am J Otolaryngol 1999;20130- 132
PubMedArticle
4.
Petrus  LVLois  JFLo  WW Iatrogenically induced cortical blindness associated with leptomeningeal enhancement. AJNR Am J Neuroradiol 1998;191522- 1524
PubMed
5.
Wang  RCKatz  SELubow  M Visual loss and central venous catheterization: cortical blindness and hemianopsia after inadvertent subclavian artery entry. J Neuroophthalmol 2000;2032- 34
PubMedArticle
6.
Junck  LMarshall  WH Neurotoxicity of radiological contrast agents. Ann Neurol 1983;13469- 484
PubMedArticle
7.
Lantos  G Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material: CT and MRI studies. Neurology 1989;39567- 571
PubMedArticle
8.
Rapoport  SI Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 2000;20217- 230
PubMedArticle
9.
Marra  TRShah  MMikus  MA Transient cortical blindness due to hypertensive encephalopathy: magnetic resonance imaging correlation. J Clin Neuroophthalmol 1993;1335- 37
PubMedArticle
10.
Meltzer  CCFukui  MBKanal  ESmirniotopoulos  JG MR imaging of the meninges, pt I: normal anatomic features and nonneoplastic disease. Radiology 1996;201297- 308
PubMed
11.
Fukui  MBMeltzer  CCKanal  ESmirniotopoulos  JG MR imaging of the meninges, pt II: neoplastic disease. Radiology 1996;201605- 612
PubMed
12.
Grossman  SAKrabak  MJ Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25103- 119
PubMedArticle
×